AI assistant
SYNAPTICS Inc — Director's Dealing 2014
May 13, 2014
31479_dirs_2014-05-13_83bc6725-71fb-4dad-b254-6b12f70c0fde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNAPTICS INC (SYNA)
CIK: 0000817720
Period of Report: 2014-05-09
Reporting Person: Bergman Rick (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-09 | Common Stock | M | 25000 | $23.25 | Acquired | 54162 | Direct |
| 2014-05-09 | Common Stock | S | 22800 | $58.6348 | Disposed | 31362 | Direct |
| 2014-05-09 | Common Stock | S | 2200 | $59.2968 | Disposed | 29162 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-09 | Employee Stock Option (Right to Buy) | $23.25 | M | 25000 | Disposed | 2018-09-28 | Common Stock (25000) | Direct |
Footnotes
F1: The shares were sold pursuant to a 10b5-1 Sales Plan dated May 20, 2013.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.19 to $59.17 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $59.40 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4: 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the September 28, 2011 grant date, and 1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 28th day of each month thereafter, until fully vested on September 28, 2015.